Digital Respiratory Devices Market Size, Share, By Product (Smart Inhalers, Nebulizers Sensors, and Apps), Indication (Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Infectious Diseases), End-User (Hospitals, Homecare Settings, and Others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the target market is expected to increase at a rate of USD 553.3 Billion.
• In 2024, the digital respiratory devices market size was valued at USD 57.48 Billion.
• The market is expanding at a CAGR of 25.6%.

A digital respiratory device is a medical device that uses technology to monitor and manage respiratory condition, such as asthma, COPD and other disorders. This includes a small inhaler equipped with sensors that track usage and gives real-time collection and communication with mobile app & healthcare provider to improve treatment management.  The increasing demand for the diagnosis and treatment rate for the respiratory disorders and technological advancements is expected to drive digital respiratory devices market growth.

For instance, in April 2020, Aptar partnered with Sonmol to develop digital platform for respiratory related disorder. This collaboration aimed to bring digital platform for asthma and COPD diseases. Aptar Pharma and Sonmol worked together to expand services to enable remote patient monitoring, improve patient and physical interactions and improve health outcomes.

Impact of AI on Digital Respiratory Devices Market:

Artificial intelligence (AI) can enhance remote monitoring capabilities of the respiratory patients and getting access to medical information for personalized medicine. AI algorithms have the ability to indicate the early stage of respiratory diseases and AI assist healthcare professionals to detect respiratory conditions at early stage. By continuously monitoring patient data, such as respiratory pattern, blood gas levels, and lung mechanics, AI algorithms give real-time feedback and personalized treatment for the patient’s respiratory system.

Key Drivers of Target Market:

Increasing Incidence of Chronic Respiratory Diseases is expected to drive the Market Growth

An increasing chronic respiratory diseases, such as sleep apnea, chronic obstructive pulmonary disease (COPD) and asthma lead to drive digital respiratory devices market growth. Increasing chronic diseases due to rise in air pollution, aging population, and increasing tobacco & smoking, has raised the demand for digital respiratory devices to help patients for monitoring and reducing the risk of complication during treatment. 

• For instance, according to the article published by World Health Organization (WHO) in November 2024, the growing number of chronic respiratory disease require effective action. Each year, over 3 million of peoples are diagnosed with chronic obstructive pulmonary disease (COPD) and other respiratory disorder. The World Health Organization (WHO), promote integrating COPD diagnosis and treatment into primary health care systems.

Technological Advancements in the Respiratory Devices to Propel Market Growth

Technological advancements in the respiratory devices that focus on oxygen concentrators more efficiently, are comfortable and easy to use by the integration of smart technology, such as apps that monitor oxygen levels, track sleep patterns, and gives users to greater control over their treatment. These factors are responsible for target market growth.  Improvement in technology, gives real-time sharing with healthcare providers that allow for the personalized and responsive care.

• For instance, the article published by the Indian Express in November 2024, this article highlights, the technological advancement in continuous positive airway pressure (CACP) devices have been used to treat sleep apnea, and asthma. CACP devices contain smart features such as Bluetooth and Wi-Fi connectivity, allowing users to track their sleep data and therapy progress using mobile apps. This data is beneficial to the patients for personalized treatment.

Restraints:

Limited Availability of Skilled Professionals Can Hamper Target Market Growth

The increasing incidence of respiratory diseases is supporting to rising demand for diagnosis and treatment. The availability of skilled professions for diagnosis and treatment is low as compared to diseased patients, thus resulting in increased burden for COPD and asthma treatment among the patients.

• Counterbalance Statements:  the use of AI tools to monitor capabilities for respiratory patients will reduce the burden of professionals. AI-powered devices can collect data on lung-function, oxygen levels and other parameters and allow professionals to access respiratory care without need of frequent monitoring by diagnostics.

Opportunities & Market Trends:

High Prominence of Patient Fulfilment can Boost the Market Opportunity

The healthcare providers and diagnostics are continuously focusing to complete patients demand for the treatment of chronic respiratory disorder. Digital respiratory devices play crucial role to enhancing patient compliance by providing real-time feedback and tracking medication adherence. It is great and cost-effective opportunity for healthcare providers to improving patient compliance.

The digital respiratory devices market is segmented into product, indication, end-user, and region.

Product:

By Product the target market is categorized into smart inhalers and nebulizers sensors & apps.  The small inhalers dominated the digital respiratory devices market share due to the growing prevalence of asthma and other respiratory condition and increasing air pollution can drive the demand for the usage of small inhalers.

• For instance, in September 2021, BreatheSuite received FDA clearance for over-the-counter device to turn regular metered-dose inhalers into smart inhalers. The BreathSuite System consists of a disposable, battery-powered, and portable. BeathSuite MDI device is attached to the top of the canister of the patient’s inhaler and works together with mobile app to monitor and provide feedback on inhaler adherence and technique.

Indication:

By indication, digital respiratory devices market is divided into sleep apnea, chronic obstructive pulmonary disease (COPD), asthma, and infectious diseases. The chronic obstructive pulmonary disease segment is expected to dominate the target market share due to rising focus of key players to develop and introduce new products with enhanced capabilities to diagnose COPD among patients.

• For instance, according to data provided by Medclin Research Private Limited in July 2024, respiratory diseases are increasing in India due to increasing air pollution throughout the country. The COPD respiratory disease that constitute of various upper or lower respiratory tract diseases are treated using therapeutic class of medicine, such as antibiotics, cough & cold preparation, pain relievers and respiratory products.

End-User:

The market by end-user is segmented into hospitals, homecare settings, and others. The hospitals segment is dominating the target market due to the efficient and reliable tools used in digital respiratory devices, rapid improvements in healthcare infrastructure, public-private partnerships, and increased access to healthcare services are expected to drive target market.

Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

 North America: North America is the most dominating region for digital respiratory devices market due to high rates of chronic respiratory diseases, such as asthma and COPD. Also, there is a well-developed healthcare infrastructure and rising public awareness can increase the demand for the respiratory devices to treat COPD, this is expected to drive target market growth. 

• For instance, in September 2024, Verdian expands respiratory device portfolio with acquisition of Zewa to offer and expands its remote patients monitoring and telehealth product sectors. Zewa bring a range of products, respiratory devices such as compressor nebulizers, oximetry, blood pressure monitors, pain management products, and thermometry.

Aisa Pacific: Asia Pacific is expected to witness fastest growth in the market due to the rising number of COPD and asthma incident rates in China and India. Thus, technological advancements in respiratory devices to treat respiratory diseases will drive the target market growth in upcoming years.

Digital Respiratory Devices Market Report Scope:

Segmentation:

By Product:

• Smart Inhalers
• Nebulizers Sensors & Apps

By Indication:

• Sleep Apnea
• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Infectious diseases

By End-User:

• Hospitals
• Homecare Settings
• Other Settings.

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the digital respiratory devices market include Amiko Digital Health Limited, Cognita Labs, AptarGroup, Inc., and other companies are cautiously investing in the market development including new product launches, partnerships, agreement, higher investments and collaboration with other organization. This competitive environment inspires for technological innovation and dive the target market share growth.

List of Key Players in the Market:

• Amiko Digital Health Limited
• Cognita Labs
• AptarGroup, Inc.
• Adherium
• Teva Pharmaceutical Industries Ltd.
• 3M
• Sensiron AG
• Fisher & Paykel Healthcare Limited
• Welch Allyn, Inc.
• Propeller Health
• Koninklijke Philips N.V.
• Stryker
• Trivitron Healthcare

• In October 2024, Honeywell announced long-term supply agreement with DevPro Biopharma to develop a respiratory inhaler to enhance the well-being of patients and reduce carbon emissions associated with traditional inhalers. The Honeywell Solstice Air HFO-1234ze technology designed to treat patients with asthma and COPD diseases. The albuterol inhaler designed to reduce environmental impact by maintaining its efficacy in treating respiratory conditions
• In February 2022, Aptar Pharma launched HeroTracker Sense, a novel connected smart device for respiratory diseases. HeroTracker Sense is designed to help patients live around the world that are suffering from asthma, COPD, Cystic Fibrosis and other respiratory conditions caused by COVID-19. It is used to track MDI usage and facilitate improved adherence to their prescribed therapy. The sensors in the device enables the creation and supply of information, such as co-ordination of inspiration, inhalation duration and flow rate.  

Analyst View:

Digital respiratory devices market is significantly growing due to increasing prevalence of respiratory diseases, such as asthma, COPD, sleep apnea and other chronic disorder. Some factors such as, rise in aging population and technological advancement in digital devices, resulting in the target market growth in upcoming years.

More Related Reports

Digital Fluoroscopy System Market
Digital Health Market
Digital Pathology Market
Respiratory Device Market
Respiratory Protective Equipment Market